GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary

Kidney Int. 2025 May;107(5):767-771. doi: 10.1016/j.kint.2024.12.019.
No abstract available

Publication types

  • Editorial